Research Project

Project Title:	AN EXTENDED ACCESS PROGRAM TO ASSESS LONG TERM SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH CHRONIC KIDNEY DISEASE (EAGLE)
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Hereditary glomerulopathies
Project Summary:	This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with chronic kidney disease (CKD) who previously participated in one of the qualifying clinical studies with bardoxolone methyl. Patients will remain in the study until bardoxolone methyl is available through commercial channels or until patient withdrawal, whichever is sooner.
Lead principal investigator(s):	Bertrand Knebelmann, Paris
Co-investigator(s):	Myriam Dao, Paris Aurélie Hummel, Paris
Project Period:	03/2019 - 12/2025
ClinicalTrials.gov:	NCT03749447
EudraCT Nr.:	2018-003253-24